Pricing Log in Create free account

Janux Therapeutics, Inc. (JANX) vs Vor Biopharma Inc. (VOR)

Janux Therapeutics, Inc. and Vor Biopharma Inc. are both Biotechnology companies. Janux Therapeutics, Inc. and Vor Biopharma Inc. are of similar size ($1.1B and $1.1B). Vor Biopharma Inc. has the higher net margin (0.00% vs −427.5%) and the higher return on invested capital (0.00% vs 0.00%). Across the 12 metrics below, Janux Therapeutics, Inc. leads on 8 and Vor Biopharma Inc. on 4.

Valuation

Metric JANX VOR Biotechnology median
P/E n/m n/m 8.50
P/S 43.24 n/m 9.71
P/B 1.12 6.97 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m n/m 0.64
EV/Sales 2.79 n/m 9.21
Earnings yield (9.95%) (2,102.61%) (33.15%)
Free cash flow yield (4.04%) (7.76%) (25.50%)

Profitability

Metric JANX VOR Biotechnology median
Gross margin 100.00% 0.00% 65.16%
Operating margin (598.15%) — 0.00%
Net margin (427.47%) 0.00% 0.00%
Free cash flow margin (174.69%) 0.00% 0.00%
Return on equity (10.70%) (69.27%) (56.36%)
Return on assets (10.06%) 0.00% (48.04%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric JANX VOR Biotechnology median
Revenue growth (TTM) 83.92% — 6.02%
EPS growth (last fiscal year) (42.97%) (107.35%) 30.26%
Revenue growth, 5-year CAGR — — 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric JANX VOR Biotechnology median
Debt to equity 0.00 0.21 0.00
Current ratio 16.35 10.69 4.72
Net debt to EBITDA 5.58 2.27 0.96

Dividend

Metric JANX VOR Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric JANX VOR Biotechnology median
Market cap 1.06b 1.14b 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack